- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07271134
Short-term Observation on the Clinical Application Effect of Astra Tech Implant EV Short Implants for Maxillary Sinus Elevation
December 8, 2025 updated by: Linhu Wang
Short-term comparison of clinical application effects of Astra OsseoSpeed EV short implants and conventional implants for maxillary sinus elevation
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
- If the survival rate, marginal bone resorption , complications and patient satisfaction of the short implant group are comparable or better than those of the conventional implant group, then short implants can be regarded as an effective treatment option for insufficient alveolar bone in the posterior teeth area. Thus, in clinical practice, the investigators can utilize short implants combined with transcrestal sinus floor elevation, or even implant short implants to help patients with certain insufficient maxillary bone complete implant restoration without resorting to more complex, costly and more invasive external elevation surgery to increase the length of posterior teeth implants in the maxillary region.
- If it is found that the short implant group has a higher incidence of complications or a lower long-term survival rate, further exploration of its indications and optimization of surgical strategies is required.
Study Type
Interventional
Enrollment (Estimated)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: lin hu Wang, Doctoral
- Phone Number: +8618086060633
- Email: 316036445@qq.com
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 422202
- No. 26, Shengli Street, Jiang'an District, Wuhan City, Hubei Province, China
-
Contact:
- lin hu Wang, Doctor's degree
- Phone Number: +8618086060633
- Email: 316036445@qq.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Patients aged over 18 years old with at least one area of the posterior dental arch having insufficient alveolar bone height (3-6 mm)
- Patients are in good health and have no major systemic diseases such as diabetes or cardiovascular diseases, and no maxillary sinus lesions
- They are willing to undergo implant restoration treatment and can complete at least 3-year follow-up.
Exclusion Criteria:
- horizontal bone deficiency alveolar ridges,bone defects caused by tumor resection
- excessive tobacco use (more than 10 cigarettes per day)
- severe liver and kidney diseases
- history of radiotherapy and chemotherapy in the head and neck region
- uncontrolled diabetes
- active periodontal disease
- oral mucosal diseases in the treatment area or poor oral hygiene,
- PI > 70%
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: transcrestal sinus floor elevation
|
Short-term clinical outcome of Astra OsseoSpeed EV short implants (L=6.3mm) for transcrestal sinus floor elevation
Short-term clinical outcome of Astra OsseoSpeed EV short implants (L=8mm) for transcrestal sinus floor elevation
conventional implants (L=9mm) in the posterior maxillary region for dental restoration
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Various complications
Time Frame: From having a tooth implant to one year after wearing the dentures
|
the rate of Implant survival, swelling, pain, etc.
|
From having a tooth implant to one year after wearing the dentures
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
marginal bone resorption
Time Frame: one year
|
Measure the changes in the bone height around the implant
|
one year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient satisfaction
Time Frame: From having a tooth implant to one year after wearing the dentures
|
Very satisfied, satisfied, dissatisfied, the rate of dissatisfaction, etc.
|
From having a tooth implant to one year after wearing the dentures
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 10, 2025
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
July 30, 2028
Study Registration Dates
First Submitted
November 22, 2025
First Submitted That Met QC Criteria
December 6, 2025
First Posted (Estimated)
December 9, 2025
Study Record Updates
Last Update Posted (Actual)
December 16, 2025
Last Update Submitted That Met QC Criteria
December 8, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WHZXKYL2025-123
- I-AS-25-105 (Other Grant/Funding Number: DENTSPLY IH AB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Methods and Results
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.